Literature DB >> 11937265

Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia.

Koichi Nakase1, Fumihiko Ishimaru, Keiko Fujii, Takayuki Tabayashi, Teruhiko Kozuka, Nobuo Sezaki, Yoshinobu Matsuo, Mine Harada.   

Abstract

OBJECTIVE: In previous studies, we demonstrated overexpression of the dominant-negative isoform of the transcription factor Ikaros, Ik-6, in patients with blast crisis of chronic myelogenous leukemia and B-cell acute lymphoblastic leukemia. In the present study, we analyzed expression of the Ikaros family genes Ikaros, Aiolos, and Helios in a panel of human T-cell leukemia/lymphoma cell lines and bone marrow samples of patients with T-cell acute lymphoblastic leukemia.
MATERIALS AND METHODS: We performed reverse transcriptase polymerase chain reaction, sequencing analysis, immunoblotting, and Southern blotting.
RESULTS: We found overexpression of novel short isoforms of Helios (Hel-5 and Hel-6) in the HD-Mar cell line. Southern blot analysis suggested that there might be a small deletion in the Helios locus of HD-Mar. In addition, we observed decreased expression of more than one Ikaros family gene in 3 of 9 patients with T-cell acute lymphoblastic leukemia. Moreover, one of the patients overexpressed novel short isoforms of Helios (Hel-7 and Hel-8).
CONCLUSION: This study provides the first evidence of an Ikaros family member (other than Ikaros) of which novel short isoforms become overexpressed in human leukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937265     DOI: 10.1016/s0301-472x(01)00796-2

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice.

Authors:  Zheng Zhang; C Scott Swindle; John T Bates; Rose Ko; Claudiu V Cotta; Christopher A Klug
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

Review 2.  Helios: still behind the clouds.

Authors:  Angela M Thornton; Ethan M Shevach
Journal:  Immunology       Date:  2019-10-13       Impact factor: 7.397

Review 3.  Ikaros and tumor suppression in acute lymphoblastic leukemia.

Authors:  Kimberly J Payne; Sinisa Dovat
Journal:  Crit Rev Oncog       Date:  2011

4.  High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma.

Authors:  Bufang Xu; Fengjie Liu; Yumei Gao; Jingru Sun; Yingyi Li; Yuchieh Lin; Xiangjun Liu; Yujie Wen; Shengguo Yi; Jingyang Dang; Ping Tu; Yang Wang
Journal:  Acta Derm Venereol       Date:  2021-12-07       Impact factor: 3.875

5.  Role of a non-canonical splice variant of the Helios gene in the differentiation of acute lymphoblastic leukemic T cells.

Authors:  Yinghui Li; Yanhua Liu; Can Liu; Fengyong Liu; Daolei Dou; Wenjie Zheng; Wei Liu; Feifei Liu
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

6.  Possible involvement of Helios in controlling the immature B cell functions via transcriptional regulation of protein kinase Cs.

Authors:  Hidehiko Kikuchi; Masami Nakayama; Yasunari Takami; Futoshi Kuribayashi; Tatsuo Nakayama
Journal:  Results Immunol       Date:  2011-11-12

7.  Helios expression is a marker of T cell activation and proliferation.

Authors:  Tatiana Akimova; Ulf H Beier; Liqing Wang; Matthew H Levine; Wayne W Hancock
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

8.  The combined expression patterns of Ikaros isoforms characterize different hematological tumor subtypes.

Authors:  Carlos A Orozco; Andrés Acevedo; Lazaro Cortina; Gina E Cuellar; Mónica Duarte; Liliana Martín; Néstor M Mesa; Javier Muñoz; Carlos A Portilla; Sandra M Quijano; Guillermo Quintero; Miriam Rodriguez; Carlos E Saavedra; Helena Groot; María M Torres; Valeriano López-Segura
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.